Sort   by:  
 Page size 
UnknownNelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial.

Background

Nelonemdaz is a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, as proven in preclinical ischemia-reperfusion studies. We aimed to evaluate the safety and efficacy of nelonemdaz in patients with acute ischemic stroke ...
S-EPMC9586831 | biostudies-literature
UnknownComprehensive Introduction to ASIAN-HF Registry.

Study type

A Prospective Observational Study Study Period: 2012-09 to 2020-03 Study Data Overview (ASIAN HF Registry, A Prospective Observational Study [ASIANHF]; NCT01633398).
S-EPMC12426648 | biostudies-literature
UnknownNew-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry.

Background and aims

Data on new-onset atrial fibrillation (NOAF) in patients with chronic coronary syndromes (CCS) are scarce. This study aims to describe the incidence, predictors, and impact on cardiovascular (CV) outcomes of NOAF in CCS patients.

Methods

Data from the international...
S-EPMC10834159 | biostudies-literature
Sort   by:  
 Page size